2023
DOI: 10.1053/j.gastro.2023.07.017
|View full text |Cite
|
Sign up to set email alerts
|

Ceramides Increase Fatty Acid Utilization in Intestinal Progenitors to Enhance Stemness and Increase Tumor Risk

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
5
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 18 publications
(5 citation statements)
references
References 47 publications
0
5
0
Order By: Relevance
“…Low FASM-risk patients get more satisfactory clinical benefits after immune checkpoint (PD-1/PD- L1) blockade therapies. Furthermore, the enhanced stemness of tumor cells caused by abnormal FAs metabolism reduces the survival time of patients and increases the possibility of cancer recurrence [ 60 , 61 ]. Consequently, CSC niches works by recruiting immunosuppressive cells, such as cancer-associated fibroblasts, Tregs and M2 macrophages to enhance their pro-tumor activity [ 62 ].…”
Section: Discussionmentioning
confidence: 99%
“…Low FASM-risk patients get more satisfactory clinical benefits after immune checkpoint (PD-1/PD- L1) blockade therapies. Furthermore, the enhanced stemness of tumor cells caused by abnormal FAs metabolism reduces the survival time of patients and increases the possibility of cancer recurrence [ 60 , 61 ]. Consequently, CSC niches works by recruiting immunosuppressive cells, such as cancer-associated fibroblasts, Tregs and M2 macrophages to enhance their pro-tumor activity [ 62 ].…”
Section: Discussionmentioning
confidence: 99%
“…Ceramides also promote progression of metabolic dysfunction-associated steatohepatitis (MASH), a well-established risk factor for HCC (Chaurasia et al, 2019). We have previously proposed that modest increases of ceramides, at levels that are insufficient to induce apoptosis, reprogram metabolism in cells in a manner that might be protumorigenic(Li et al, 2023). Two of our findings in this study provide additional evidence supporting a tumor-promoting role for ceramides in HCC.…”
Section: Discussionmentioning
confidence: 99%
“…Deletion of SPT subunit, SPTLC2, inhibits ISC proliferation in mice. 77 Similarly, disruption of SPT homologue lace or the ceramide synthase homologue schlank in Drosophila recapitulates the phenotype. 77 Conversely, treating Sptlc2 ‐knockout organoids with a ceramide analogue, C 2 ‐ceramide, rescues ISC proliferation.…”
Section: Metabolic Control Of Isc Homeostasismentioning
confidence: 97%
“… 77 Similarly, disruption of SPT homologue lace or the ceramide synthase homologue schlank in Drosophila recapitulates the phenotype. 77 Conversely, treating Sptlc2 ‐knockout organoids with a ceramide analogue, C 2 ‐ceramide, rescues ISC proliferation. RNA‐seq analysis revealed that ceramide activates fatty acid‐binding protein 1 (FABP1) through PPARα, which enhances fatty acid utilisation and ISC proliferation.…”
Section: Metabolic Control Of Isc Homeostasismentioning
confidence: 97%
See 1 more Smart Citation